These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2403975)

  • 1. Histopathologic analysis of suspected amiodarone hepatotoxicity.
    Lewis JH; Mullick F; Ishak KG; Ranard RC; Ragsdale B; Perse RM; Rusnock EJ; Wolke A; Benjamin SB; Seeff LB
    Hum Pathol; 1990 Jan; 21(1):59-67. PubMed ID: 2403975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease.
    Guigui B; Perrot S; Berry JP; Fleury-Feith J; Martin N; Métreau JM; Dhumeaux D; Zafrani ES
    Hepatology; 1988; 8(5):1063-8. PubMed ID: 3417226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone hepatotoxicity. A clinicopathologic study of five patients.
    Rigas B; Rosenfeld LE; Barwick KW; Enriquez R; Helzberg J; Batsford WP; Josephson ME; Riely CA
    Ann Intern Med; 1986 Mar; 104(3):348-51. PubMed ID: 3946978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies.
    Poucell S; Ireton J; Valencia-Mayoral P; Downar E; Larratt L; Patterson J; Blendis L; Phillips MJ
    Gastroenterology; 1984 May; 86(5 Pt 1):926-36. PubMed ID: 6706074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone hepatotoxicity simulating alcoholic liver disease.
    Simon JB; Manley PN; Brien JF; Armstrong PW
    N Engl J Med; 1984 Jul; 311(3):167-72. PubMed ID: 6738602
    [No Abstract]   [Full Text] [Related]  

  • 6. [Severe hepatotoxicity caused by amiodarone: description of a case].
    Latorre G; Lucas I; Herrero JI; Sangro B; Quiroga J; Sola JJ; Díaz L; Prieto J
    Rev Med Univ Navarra; 1999; 43(2):86-91. PubMed ID: 11256009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic liver disease after low daily doses of amiodarone. Report of three cases.
    Babany G; Mallat A; Zafrani ES; Saint-Marc Girardin MF; Carcone B; Dhumeaux D
    J Hepatol; 1986; 3(2):228-32. PubMed ID: 3794303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal hepatotoxicity following oral administration of amiodarone.
    Richer M; Robert S
    Ann Pharmacother; 1995 Jun; 29(6):582-6. PubMed ID: 7663029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients.
    Lewis JH; Ranard RC; Caruso A; Jackson LK; Mullick F; Ishak KG; Seeff LB; Zimmerman HJ
    Hepatology; 1989 May; 9(5):679-85. PubMed ID: 2785079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of population modeling to define rational monitoring of amiodarone hepatic effects.
    Pollak PT; Shafer SL
    Clin Pharmacol Ther; 2004 Apr; 75(4):342-51. PubMed ID: 15060512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcoholic liver disease: pathologic, pathogenetic and clinical aspects.
    Ishak KG; Zimmerman HJ; Ray MB
    Alcohol Clin Exp Res; 1991 Feb; 15(1):45-66. PubMed ID: 2059245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems in the necropsy diagnosis of alcoholic liver disease.
    Pounder DJ
    Am J Forensic Med Pathol; 1984 Jun; 5(2):103-9. PubMed ID: 6731401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granular cells as a marker of early amiodarone hepatotoxicity: a pathological and analytical study.
    Shepherd NA; Dawson AM; Crocker PR; Levison DA
    J Clin Pathol; 1987 Apr; 40(4):418-23. PubMed ID: 3584485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxicity associated with amiodarone therapy.
    Flaharty KK; Chase SL; Yaghsezian HM; Rubin R
    Pharmacotherapy; 1989; 9(1):39-44. PubMed ID: 2646621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal amiodarone hepatoxicity.
    Gilinsky NH; Briscoe GW; Kuo CS
    Am J Gastroenterol; 1988 Feb; 83(2):161-3. PubMed ID: 3341340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dense liver in a 72-year-old woman with congestive heart failure.
    Jones WP; Shin MS; Stanley RJ; Duncan-Myers J
    Invest Radiol; 1985 Dec; 20(9):911-5. PubMed ID: 4077446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use.
    Raja K; Thung SN; Fiel MI; Chang C
    Semin Liver Dis; 2009 Nov; 29(4):423-8. PubMed ID: 19826976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute hepatopathy caused by amiodarone. Study of a case and review of the literature].
    Capron-Chivrac D; Reix N; Quénum C; Capron JP
    Gastroenterol Clin Biol; 1985; 9(6-7):535-9. PubMed ID: 4018488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causality assessment of liver injury after chronic oral amiodarone intake.
    Llanos L; Moreu R; Peiró AM; Pascual S; Francés R; Such J; Horga JF; Pérez-Mateo M; Zapater P
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):291-300. PubMed ID: 19165760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report.
    Oikawa H; Maesawa C; Sato R; Oikawa K; Yamada H; Oriso S; Ono S; Yashima-Abo A; Kotani K; Suzuki K; Masuda T
    World J Gastroenterol; 2005 Sep; 11(34):5394-7. PubMed ID: 16149155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.